(Q43193136)

15 November 2017

0 references

Glomerular filtration rate: screening cannot be recommended on the basis of current knowledge (English)

1 reference

15 November 2017

Catherine M Clase

1

1 reference

PMC publication ID

1647391

15 November 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

15 November 2017

1 reference

15 November 2017

333

1 reference

15 November 2017

7577

1 reference

15 November 2017

1030-1031

1 reference

Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey

15 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1647391

Low protein diets for chronic kidney disease in non diabetic adults

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1647391

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1647391

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1647391

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1647391

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1647391

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1647391

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLH

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1647391

Unreferred chronic kidney disease: a longitudinal study

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1647391

Effects of labelling on income, work and social function among hypertensive employees

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17110701

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.39030.594259.BE

1 reference

15 November 2017

1 reference

PMC publication ID

1647391

15 November 2017

PubMed publication ID

17110701

1 reference

PMC publication ID

1647391